NCT05790941View on ClinicalTrials.gov

Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 11, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Hypotrichosis
Interventions
COMBINATION_PRODUCT

Latanoprost and Minoxidil

Latanoprost and Minoxidil formulation for the treatment of hypotrichosis of the eyebrows.

Trial Locations (1)

92210

RECRUITING

WellMax, Indian Wells

Sponsors
All Listed Sponsors
lead

Aneira Pharma, Inc.

INDUSTRY

NCT05790941 - Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation | Biotech Hunter | Biotech Hunter